These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31983747)

  • 1. The Lipo- Phenotypic Screening Tool for Familial Hypercholesterolaemia.
    Kalra S; Kishor K; Sawhney J; Kumar K; Raza SA; Shrestha D; Aye TT; Chaudhary S; Shaikh K; Somasundaram N; Pathan F; Sahay R; Priya G
    J Pak Med Assoc; 2019 Jul; 69(7):1052-1054. PubMed ID: 31983747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing a national screening programme for familial hypercholesterolaemia in Lithuania.
    Petrulioniene Z; Gargalskaite U; Kutkiene S; Staigyte J; Cerkauskiene R; Laucevicius A
    Atherosclerosis; 2018 Oct; 277():407-412. PubMed ID: 30270078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: Importance of early detection and lifestyle advice.
    Pang J; David Marais A; Blom DJ; Brice BC; Silva PR; Jannes CE; Pereira AC; Hooper AJ; Ray KK; Santos RD; Watts GF
    Atherosclerosis; 2018 Oct; 277():470-476. PubMed ID: 30270087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy).
    Descamps OS; Van Caenegem O; Hermans MP; Balligand JL; Beauloye C; Bondue A; Carlier S; Castermans E; Chenot F; Claeys M; De Block C; de Leener A; De Meester A; Demeure F; De Raedt H; Desmet W; Elegeert I; Guillaume M; Hoffer E; Kacenelenbogen R; Lancellotti P; Langlois M; Leone A; Mertens A; Paquot N; Vanakker O; Vanoverschelde JL; Verhaegen A; Vermeersch P; Wallemacq C; Rietzschel E;
    Atherosclerosis; 2018 Oct; 277():369-376. PubMed ID: 30270073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced status of inflammation and endothelial activation in subjects with familial hypercholesterolaemia and their related unaffected family members: a case control study.
    Rahman T; Hamzan NS; Mokhsin A; Rahmat R; Ibrahim ZO; Razali R; Thevarajah M; Nawawi H
    Lipids Health Dis; 2017 Apr; 16(1):81. PubMed ID: 28438163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of families.
    Truong TH; Kim NT; Nguyen MNT; Pang J; Hooper AJ; Watts GF; Do DL
    Atherosclerosis; 2018 Oct; 277():392-398. PubMed ID: 30270076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
    Pérez de Isla L; Alonso R; Mata N; Saltijeral A; Muñiz O; Rubio-Marin P; Diaz-Diaz JL; Fuentes F; de Andrés R; Zambón D; Galiana J; Piedecausa M; Aguado R; Mosquera D; Vidal JI; Ruiz E; Manjón L; Mauri M; Padró T; Miramontes JP; Mata P;
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2004-10. PubMed ID: 27444203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales.
    Haralambos K; Whatley SD; Edwards R; Gingell R; Townsend D; Ashfield-Watt P; Lansberg P; Datta DB; McDowell IF
    Atherosclerosis; 2015 May; 240(1):190-6. PubMed ID: 25797312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new electronic screening tool for identifying risk of familial hypercholesterolaemia in general practice.
    Troeung L; Arnold-Reed D; Chan She Ping-Delfos W; Watts GF; Pang J; Lugonja M; Bulsara M; Mortley D; James M; Brett T
    Heart; 2016 Jun; 102(11):855-61. PubMed ID: 26864669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of familial hypercholesterolaemia: Community and clinical.
    Vallejo-Vaz AJ; Ray KK
    Atherosclerosis; 2018 Oct; 277():289-297. PubMed ID: 30270061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for familial hypercholesterolaemia in primary care: Time for general practice to play its part.
    Brett T; Qureshi N; Gidding S; Watts GF
    Atherosclerosis; 2018 Oct; 277():399-406. PubMed ID: 30270077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunistic screening for familial hypercholesterolaemia via a community laboratory.
    Bell DA; Hooper AJ; Bender R; McMahon J; Edwards G; van Bockxmeer FM; Watts GF; Burnett JR
    Ann Clin Biochem; 2012 Nov; 49(Pt 6):534-7. PubMed ID: 23002132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of Familial Hypercholesterolemia and High Low-Density Lipoprotein Cholesterol to Ischemic Stroke: Copenhagen General Population Study.
    Beheshti S; Madsen CM; Varbo A; Benn M; Nordestgaard BG
    Circulation; 2018 Aug; 138(6):578-589. PubMed ID: 29593013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving identification and management of familial hypercholesterolaemia in primary care: Pre- and post-intervention study.
    Weng S; Kai J; Tranter J; Leonardi-Bee J; Qureshi N
    Atherosclerosis; 2018 Jul; 274():54-60. PubMed ID: 29751285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
    deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation.
    Watts GF; Gidding S; Wierzbicki AS; Toth PP; Alonso R; Brown WV; Bruckert E; Defesche J; Lin KK; Livingston M; Mata P; Parhofer KG; Raal FJ; Santos RD; Sijbrands EJ; Simpson WG; Sullivan DR; Susekov AV; Tomlinson B; Wiegman A; Yamashita S; Kastelein JJ;
    Eur J Prev Cardiol; 2015 Jul; 22(7):849-54. PubMed ID: 24776375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis and genotype-phenotype relation in familial hypercholesterolemia: The SAFEHEART registry.
    Bourbon M; Alves AC; Alonso R; Mata N; Aguiar P; Padró T; Mata P
    Atherosclerosis; 2017 Jul; 262():8-13. PubMed ID: 28475941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study.
    Casula M; Olmastroni E; Pirillo A; Catapano AL; ; ; ; ; ;
    Atherosclerosis; 2018 Oct; 277():413-418. PubMed ID: 30270079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience.
    Bell DA; Pang J; Burrows S; Bates TR; van Bockxmeer FM; Hooper AJ; O'Leary P; Burnett JR; Watts GF
    Atherosclerosis; 2015 Mar; 239(1):93-100. PubMed ID: 25585028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial hypercholesterolemia screening program in Bosnia and Herzegovina and cardiovascular morbidity.
    Pojskic L; Pojskic B
    Atherosclerosis; 2018 Oct; 277():278-281. PubMed ID: 30270059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.